首页> 外文OA文献 >Increased levels of soluble interleukin-6 receptor and CCL3 in COPD sputum.
【2h】

Increased levels of soluble interleukin-6 receptor and CCL3 in COPD sputum.

机译:COpD痰液中可溶性白细胞介素-6受体和CCL3水平升高。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BACKGROUND: COPD patients have increased numbers of macrophages and neutrophils in the lungs. Interleukin-6 (IL-6) trans-signaling via its soluble receptor sIL-6R, governs the influx of innate immune cells to inflammatory foci through regulation of the chemokine CCL3. We hypothesized that there would be enhanced levels of IL-6, sIL-6R and CCL3 in COPD sputum. METHODS: 59 COPD patients, 15 HNS and 15 S underwent sputum induction and processing with phosphate buffered saline to obtain supernatants for IL-6, sIL-6R and CCL3 analysis. Cytoslides were produced for differential cell counting and immunocytochemistry (COPD; n = 3) to determine cell type surface expression of the CCL3 receptors CCR5 and CCR1. RESULTS: COPD patients expressed higher levels (p 
机译:背景:COPD患者肺部巨噬细胞和中性粒细胞数量增加。白细胞介素6(IL-6)通过其可溶性受体sIL-6R进行信号转导,通过调节趋化因子CCL3来控制先天免疫细胞向炎症灶的流入。我们假设COPD痰液中IL-6,sIL-6R和CCL3的水平会升高。方法:对59例COPD患者,15例HNS和15 S进行痰诱导,并用磷酸盐缓冲液处理以获得上清液,用于IL-6,sIL-6R和CCL3分析。产生细胞滑片用于差异细胞计数和免疫细胞化学(COPD; n = 3),以确定CCL3受体CCR5和CCR1的细胞类型表面表达。结果:COPD患者表达较高水平(p

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号